Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. Top Stock Analyzer Message Board

$BIEL Synopses of three case studies "These

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 10156
(Total Views: 160)
Posted On: 01/24/2023 7:55:40 AM
Avatar
Posted By: Tsongbird
$BIEL Synopses of three case studies


Quote:

"These cases demonstrate that following knee and hip arthroplasty, the
use of pulsed shortwave therapy devices is feasible in both the in- and
out-patient settings and may improve analgesia while decreasing—perhaps sometimes obviating—opioid consumption." Full article
here: https://www.fortunejournals.com/articles/noni...series.pdf





Quote:

"These cases suggest that pulsed electromagnetic field therapy may be an
effective treatment for intractable postamputation pain. Considering the
low patient burden of noninvasive, wearable devices, combined with few
contraindications and no significant side effects or adverse events,
further study with a randomized, controlled trial is warranted." (that
further study is underway at UC San Diego) Full article
here: https://amjcaserep.com/abstract/full/idArt/937549





Quote:
RecoveryRx was recently used in a series of cases at UC San Diego. This
is from this published case report: "Following moderately painful
ambulatory umbilical (n=3) and inguinal (n=2) hernia repair as well as
bilateral breast surgery (n=2),patients had taped over their incision(s)
1 or 2 nonivasive, wearable, disposable, pulsed shortwave therapy
devices (RecoveryRx)which functioned continuously for 30 days. Average
resting pain scores measured on the 0-10 numeric rating scale were a
median of 0 during the entire treatment period. Six patients avoided
opioid use entirely, while the remaining individual required only 5 mg
of oxycodone during the first postoperative day."
The full case study is available here: https://pubmed.ncbi.nlm.nih.gov/36463434



912916250_recoveryrxpostop.jpg

1784623575_actipatch.jpg


(1)
(0)




Live Laugh Love

Favorite Stocks
$BIEL Bioelectronics https://www.bielcorp.com/




Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us